Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.

Poor prognosis of hepatocellular carcinoma (HCC) is associated with a high potential of vascular invasion and metastasis. Epithelial-mesenchymal transition (EMT) is a key event in the tumor invasion process. Recently, signal transducers and activators of transcription 5 (STAT5) has been linked to tumor progression by EMT induction. However, the precise roles of STAT5 genes (STAT5a and STAT5b) in human epithelial cancers have not been elucidated clearly. The aim of this study is to analyze the roles of STAT5 isoforms in HCC progression using HCC clinical samples. We showed that activation of STAT5b, but not STAT5a, was found in HCC clinical samples and its expression was significantly associated with younger age (P = 0.037), advanced tumor stages (P = 0.003), venous infiltration (P = 0.016), microsatellite formation (P = 0.024), multiple tumor nodules (P = 0.02), and poor patient survival. To specifically investigate the mechanism underlying constitutive activation of STAT5b in HCC, EGFP-HBX was introduced into Huh-7 cells. STAT5b activation in HCC is at least partially mediated by HBX activation. Ectopic STAT5b transfection conferred increased HCC cell motility and invasiveness by induction of EMT changes. In conclusion, STAT5b activation enhanced HCC aggressiveness by induction of EMT, which was possibly mediated by HBX activation. STAT5b could serve as a novel molecular target for HCC treatment.

[1]  S. Ye,et al.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. , 2001, World journal of gastroenterology.

[2]  S. Fan,et al.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.

[3]  S. Hirohashi.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. , 1998, The American journal of pathology.

[4]  Alan Cantor,et al.  Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression , 2006, Clinical Cancer Research.

[5]  K. Sugimachi,et al.  Altered Expression of β-Catenin without Genetic Mutation in Intrahepatic Cholangiocarcinoma , 2001, Modern Pathology.

[6]  J. Xie,et al.  Signal transducer and activator of transcription-5 activation and breast cancer prognosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  B. Beattie,et al.  Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. , 1999, Blood.

[8]  J. Rosen,et al.  Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  C. Janeway,et al.  STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. , 1999, Science.

[10]  Jens Schneider-Mergener,et al.  SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130* , 2003, The Journal of Biological Chemistry.

[11]  S. Parsons,et al.  STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor* , 2003, The Journal of Biological Chemistry.

[12]  H. Adami,et al.  The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis , 2001, Hepatology.

[13]  A. Capovilla,et al.  Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen‐activated protein kinase and JAK/STAT pathways , 2000, Journal of gastroenterology and hepatology.

[14]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Leonard,et al.  Cloning of Human Stat5B , 1996, The Journal of Biological Chemistry.

[16]  E. Gehan,et al.  Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence , 2005, Clinical Cancer Research.

[17]  E. Gehan,et al.  Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers , 2004, International journal of cancer.

[18]  B. Groner,et al.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. , 1995, The EMBO journal.

[19]  H. Rui,et al.  STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA. , 2003, Molecular biology of the cell.

[20]  Matthew B. Wilson,et al.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells , 2002, The EMBO journal.

[21]  J. Xie,et al.  Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade , 2004, Cancer Research.

[22]  M. Mitsunobu,et al.  Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel. , 1996, The American journal of gastroenterology.

[23]  Y. Yun,et al.  HBx Protein of Hepatitis B Virus Activates Jak1-STAT Signaling* , 1998, The Journal of Biological Chemistry.

[24]  P. Coffer,et al.  The role of STATs in myeloid differentiation and leukemia , 2000, Oncogene.

[25]  J. Grandis,et al.  Constitutive activation of Stat5b contributes to carcinogenesis in vivo. , 2003, Cancer research.

[26]  N. Nagasue,et al.  Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. , 1997, Surgery.

[27]  R. Behringer,et al.  Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. , 2002, Developmental biology.

[28]  F. Portillo,et al.  Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.

[29]  J. Grandis,et al.  Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. , 2007, Journal of the National Cancer Institute.

[30]  Heinz Höfler,et al.  Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.

[31]  A. Sultan,et al.  Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells , 2005, Oncogene.

[32]  T. Yamane,et al.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. , 1982, Cancer research.

[33]  H. Endo,et al.  Thrombopoietin Regulates Bcl-xL Gene Expression through Stat5 and Phosphatidylinositol 3-Kinase Activation Pathways* , 2002, The Journal of Biological Chemistry.

[34]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.